No Data
Key points of interest in the PTS on the 7th = Kawasaki Kisen, Torii Pharmaceutical, HENNG, Mercari, JT, ETC.
▽ Kawasaki Kisen <9107.T>, the consolidated operating profit Financial Estimates for the fiscal year ending March 2026 is projected to be 105 billion yen (a 66% decrease compared to the previous period). ▽ Torii Pharmaceutical <4551.T> and Shionogi <4507.T> are conducting a tender offer (Buy). The purchase price is 6,350 yen. ▽ HENNGEE <4475.T> has increased its consolidated performance Financial Estimates for the fiscal year ending September 2025. The acquisition of new orders, including large projects, exceeded expectations. ▽ Mercari <4385.T>, cumulative total for the third quarter of the fiscal year ending June 2025 (from July 2024 to March 2025).
HENNGE K.K. Reports Strong Financial Growth in First Half of 2025
HENNGE K.K. Revises Financial Forecasts Amid Strong Contract Growth
HENNGE K.K. Announces Treasury Share Acquisition to Support Stock Plans
Hennge KK: Half-Year Report - Term 29 (2024/10/01 - 2025/09/30)
Hennge 1H Net Y792.00M Vs Net Y421.00M
